<div>During its Day 2 of subscription, Remus Pharmaceuticals IPO subscribed 6.41 times and the total number of shares bid was 17,77,700 compared to the offered shares of 2,77,500. By May 18, 2023, the public offering had received subscriptions in the retail category 10.93 times, the QIB category 1.48 times, and the NII category 12.25 times. 10,62,000 shares were total bid for the retail category, compared to 97,125 shares offered; 5,09,700 shares were total bid for the NII category, compared to 41,625 shares offered; and 2,06,000 shares were total bid for the QIB category, compared to 1,38,750 shares offered.</div><div></div><div></div><div></div><div></div><div></div><div>idm 6.41 serial key.zip download</div><div></div><div>Download File:
https://t.co/TuvgKRNhLN </div><div></div><div> df19127ead</div>